Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Zubidime S 1.5 gm:
Zubidime S 1.5 gm injection is a powerful combination of Ceftazidime and Sulbactam, designed to tackle a wide range of bacterial infections, particularly those caused by resistant strains. This formulation enhances the antibacterial efficacy of Ceftazidime by protecting it from beta-lactamase enzyme degradation.
Uses of Zubidime S 1.5 gm:
Zubidime S 1.5 gm is indicated for:
Respiratory Tract Infections: Treats severe infections such as pneumonia and bronchitis.
Urinary Tract Infections: Effective in managing complicated UTIs.
Intra-abdominal Infections: Addresses peritonitis and intra-abdominal abscesses.
Skin and Soft Tissue Infections: Treats cellulitis, wound infections, and diabetic foot infections.
Bone and Joint Infections: Used for osteomyelitis and septic arthritis.
Gynecological Infections: Manages pelvic inflammatory disease and other serious infections.
Benefits of Zubidime S 1.5 gm:
Zubidime S 1.5 gm offers several benefits:
Broad-Spectrum Activity: Effective against a wide variety of Gram-positive and Gram-negative bacteria.
Enhanced Efficacy: Sulbactam protects Ceftazidime from beta-lactamase enzymes, enhancing its antibacterial effect.
Rapid Action: Provides quick relief from severe infection symptoms.
Versatile Use: Suitable for treating a range of severe infections in different body systems.
Mechanism of Action of Zubidime S 1.5 gm:
Ceftazidime: Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, leading to cell lysis and death.
Sulbactam: Inhibits beta-lactamase enzymes produced by resistant bacteria, thereby preventing the degradation of Ceftazidime and extending its spectrum of activity.
Beside this well also export in other countries